Resolvyx Pharmaceuticals, Inc.
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Resolvyx Pharmaceuticals, Inc.
Plastic Surgery Market: Fat Grafting Grabs A Hefty Slice Of The Plastics Pie
Fat, fillers, and a "funnel" that may minimize a common cause of breast implant complications are among the hot topics in both aesthetic and reconstructive plastic surgery. Meanwhile, the acquisition by Actavis of Allergan – a leading player in the aesthetics market with BOTOX and breast implants – has the combined company poised for long-term double-digit revenue and earnings growth.
Warp Drive Bio revises senior management
Dr Gregory Verdine
Celtic finalises deal to move Resolvyx' dry eye treatment through Phase III
Celtic Therapeutic Holdings, the global private equity firm, has finalised an exclusive option deal announced in October with Resolvyx Pharmaceuticals to further develop a RX-10045, a late-stage topical eye-drop that has shown potential for treating dry eye syndrome and other ophthalmic conditions. Under the terms of the deal, Celtic has acquired and licensed worldwide rights to RX-10045 in exchange for up-front consideration, near-term milestone payments, and funding for 100% of future development costs (details of all of which were undisclosed).
Deals Shaping the Medical Industry (12/2010)
The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice